Clinical Trial Update: Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Rituximab-containing regimens with either Velcade (bortezomib) or Vincristine in newly diagnosed mantle cell lymphoma; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Velcade (bortezomib)
• Vincristine (vincristine)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Mantle Cell Lymphoma | Phase 3 | Status: COMPLETED | Results posted: 2014-11-17